| Study ID | Number | Study Title | Institute | Species | Analysis |
|---|---|---|---|---|---|
| ST000004 | 5 metabolites | Lipidomics studies on NIDDK / NIST human plasma samples | LIPID MAPS | Homo sapiens | MS |
| ST000005 | 3 metabolites | Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin | LIPID MAPS | Mus musculus | MS |
| ST000046 | 1 metabolites | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Mayo Clinic | Homo sapiens | MS |
| ST000310 | 2 metabolites | TC and B6 untreated plasma in lupus-prone mice lipidomics (part-II) | University of Florida | Mus musculus | MS |
| ST000421 | 1 metabolites | Type 1 Diabetes poor glycemic control versus control samples | Mayo Clinic | Homo sapiens | MS |
| ST000549 | 2 metabolites | Investigating large scale metabolomics in mice serum lacking insulin receptors and IGF-1 receptors | Mayo Clinic | Mus musculus | MS |
| ST000566 | 1 metabolites | Large Scale C18 Profiling of the Effects of Curcumin Supplementation of Older Adults: Relation to Vascular Function (part 5) | Mayo Clinic | Homo sapiens | MS |
| ST000915 | 4 metabolites | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 1:Liver | LIPID MAPS | Homo sapiens | MS |
| ST000916 | 4 metabolites | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma | LIPID MAPS | Homo sapiens | MS |
| ST000917 | 4 metabolites | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine | LIPID MAPS | Homo sapiens | MS |
| ST001065 | 5 metabolites | Lipidomics analysis for aged mice brain cortex (part-II) | Takeda Pharmaceutical Company Limited | Mus musculus | MS |
| ST001066 | 1 metabolites | Lipidomics analysis for aged mice liver (part-III) | Takeda Pharmaceutical Company Limited | Mus musculus | MS |
| ST001288 | 3 metabolites | Subcellular organelle lipidomics in TLR-4-activated macrophages | LIPID MAPS | Mus musculus | MS |
| ST001289 | 3 metabolites | Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses | LIPID MAPS | Mus musculus | MS |
| ST001953 | 1 metabolites | Identifying metabolite changes in human islets treated with Phospho-BAD mimicry and Inflammatory cytokines | Harvard University | Homo sapiens | MS |
| ST002094 | 2 metabolites | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Mayo Clinic | Homo sapiens | MS |
| ST002970 | 1 metabolites | Untargeted metabolomics of fatty alcohol production at time 90 min of bioconversion | Vidyasirimedhi Institute of Science and Technology | Escherichia coli | MS |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|